279 related articles for article (PubMed ID: 20051130)
1. Child/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods.
Compton SN; Walkup JT; Albano AM; Piacentini JC; Birmaher B; Sherrill JT; Ginsburg GS; Rynn MA; McCracken JT; Waslick BD; Iyengar S; Kendall PC; March JS
Child Adolesc Psychiatry Ment Health; 2010 Jan; 4():1. PubMed ID: 20051130
[TBL] [Abstract][Full Text] [Related]
2. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).
Piacentini J; Bennett S; Compton SN; Kendall PC; Birmaher B; Albano AM; March J; Sherrill J; Sakolsky D; Ginsburg G; Rynn M; Bergman RL; Gosch E; Waslick B; Iyengar S; McCracken J; Walkup J
J Am Acad Child Adolesc Psychiatry; 2014 Mar; 53(3):297-310. PubMed ID: 24565357
[TBL] [Abstract][Full Text] [Related]
3. Child/Adolescent anxiety multimodal study: evaluating safety.
Rynn MA; Walkup JT; Compton SN; Sakolsky DJ; Sherrill JT; Shen S; Kendall PC; McCracken J; Albano AM; Piacentini J; Riddle MA; Keeton C; Waslick B; Chrisman A; Iyengar S; March JS; Birmaher B
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):180-90. PubMed ID: 25721183
[TBL] [Abstract][Full Text] [Related]
4. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.
Ginsburg GS; Kendall PC; Sakolsky D; Compton SN; Piacentini J; Albano AM; Walkup JT; Sherrill J; Coffey KA; Rynn MA; Keeton CP; McCracken JT; Bergman L; Iyengar S; Birmaher B; March J
J Consult Clin Psychol; 2011 Dec; 79(6):806-13. PubMed ID: 22122292
[TBL] [Abstract][Full Text] [Related]
5. Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial.
Compton SN; Peris TS; Almirall D; Birmaher B; Sherrill J; Kendall PC; March JS; Gosch EA; Ginsburg GS; Rynn MA; Piacentini JC; McCracken JT; Keeton CP; Suveg CM; Aschenbrand SG; Sakolsky D; Iyengar S; Walkup JT; Albano AM
J Consult Clin Psychol; 2014 Apr; 82(2):212-24. PubMed ID: 24417601
[TBL] [Abstract][Full Text] [Related]
6. Benefits of child-focused anxiety treatments for parents and family functioning.
Keeton CP; Ginsburg GS; Drake KL; Sakolsky D; Kendall PC; Birmaher B; Albano AM; March JS; Rynn M; Piacentini J; Walkup JT
Depress Anxiety; 2013 Sep; 30(9):865-72. PubMed ID: 23390005
[TBL] [Abstract][Full Text] [Related]
7. Secondary Outcomes From the Child/Adolescent Anxiety Multimodal Study: Implications for Clinical Practice.
Albano AM; Comer JS; Compton SN; Piacentini J; Kendall PC; Birmaher B; Walkup JT; Ginsburg GS; Rynn MA; McCracken J; Keeton C; Sakolsky DJ; Sherrill JT
Evid Based Pract Child Adolesc Ment Health; 2018; 3(1):30-41. PubMed ID: 30906874
[TBL] [Abstract][Full Text] [Related]
8. Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): Primary Anxiety Outcomes.
Ginsburg GS; Becker-Haimes EM; Keeton C; Kendall PC; Iyengar S; Sakolsky D; Albano AM; Peris T; Compton SN; Piacentini J
J Am Acad Child Adolesc Psychiatry; 2018 Jul; 57(7):471-480. PubMed ID: 29960692
[TBL] [Abstract][Full Text] [Related]
9. Monotherapy Insufficient in Severe Anxiety? Predictors and Moderators in the Child/Adolescent Anxiety Multimodal Study.
Taylor JH; Lebowitz ER; Jakubovski E; Coughlin CG; Silverman WK; Bloch MH
J Clin Child Adolesc Psychol; 2018; 47(2):266-281. PubMed ID: 28956620
[TBL] [Abstract][Full Text] [Related]
10. Trajectories of change in youth anxiety during cognitive-behavior therapy.
Peris TS; Compton SN; Kendall PC; Birmaher B; Sherrill J; March J; Gosch E; Ginsburg G; Rynn M; McCracken JT; Keeton CP; Sakolsky D; Suveg C; Aschenbrand S; Almirall D; Iyengar S; Walkup JT; Albano AM; Piacentini J
J Consult Clin Psychol; 2015 Apr; 83(2):239-52. PubMed ID: 25486372
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Initiation of Pharmacotherapy Following CBT in Anxious Youth: Results From the Child/Adolescent Anxiety Multimodal Study (CAMS).
Strawn JR; Mills JA; Rothenberg R; Piacentini J; Peris TS; McCracken JT; Walkup JT
J Clin Psychiatry; 2022 Dec; 84(1):. PubMed ID: 36479955
[No Abstract] [Full Text] [Related]
13. Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale.
Caporino NE; Brodman DM; Kendall PC; Albano AM; Sherrill J; Piacentini J; Sakolsky D; Birmaher B; Compton SN; Ginsburg G; Rynn M; McCracken J; Gosch E; Keeton C; March J; Walkup JT
J Am Acad Child Adolesc Psychiatry; 2013 Jan; 52(1):57-67. PubMed ID: 23265634
[TBL] [Abstract][Full Text] [Related]
14. Establishing Clinical Cutoffs for Response and Remission on the Screen for Child Anxiety Related Emotional Disorders (SCARED).
Caporino NE; Sakolsky D; Brodman DM; McGuire JF; Piacentini J; Peris TS; Ginsburg GS; Walkup JT; Iyengar S; Kendall PC; Birmaher B
J Am Acad Child Adolesc Psychiatry; 2017 Aug; 56(8):696-702. PubMed ID: 28735699
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
16. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186
[TBL] [Abstract][Full Text] [Related]
17. Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS).
Rabner J; Olino TM; Albano AM; Keeton CP; Sakolsky D; Birmaher B; Piacentini J; Peris TS; Compton SN; Gosch E; Ginsburg GS; Pinney EL; Kendall PC
J Child Psychol Psychiatry; 2024 Jul; 65(7):910-920. PubMed ID: 38217328
[TBL] [Abstract][Full Text] [Related]
18. Mood and suicidality outcomes 3-11 years following pediatric anxiety disorder treatment.
Keeton CP; Caporino NE; Kendall PC; Iyengar S; Lee P; Peris T; Sakolsky D; Piacentini J; Compton SN; Albano AM; Birmaher B; Ginsburg GS
Depress Anxiety; 2019 Oct; 36(10):930-940. PubMed ID: 31356713
[TBL] [Abstract][Full Text] [Related]
19. Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.
Strawn JR; Dobson ET; Mills JA; Cornwall GJ; Sakolsky D; Birmaher B; Compton SN; Piacentini J; McCracken JT; Ginsburg GS; Kendall PC; Walkup JT; Albano AM; Rynn MA
J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):501-508. PubMed ID: 28384010
[TBL] [Abstract][Full Text] [Related]
20. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
